Zobrazeno 1 - 10
of 42
pro vyhledávání: '"Nils Eide"'
Autor:
Ragnheidur Bragadottir, Demetrios G. Vavvas, Thomas Pedersen Bærland, B.L. Rekstad, Jesintha Navaratnam, Nils Eide, Rowan Thomas Faber
Publikováno v:
Ocul Oncol Pathol
Background: Early confirmation of the effect of brachytherapy for choroidal melanoma showing that tumour coverage is valuable. The irradiated retinal pigment epithelium (RPE) commonly develops atrophy. This study compares the fundus autofluorescence
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ad787dba21cc4fcbbdc063ae8eafe428
http://hdl.handle.net/10852/78294
http://hdl.handle.net/10852/78294
Autor:
Edoardo Midena, Jens Folke Kiilgaard, Mandeep S. Sagoo, Inge H. G. Bronkhorst, Victoria M L Cohen, Anna Markiewicz, Emine Kilic, Jarosław Kocięcki, Jørgen Krohn, Jacob Pe'er, Bertil Damato, Eva Biewald, Leonidas Zografos, Steffen Heegaard, Claudia H D Metz, Ann Schalenbourg, Hatem Krema, Stefan Seregard, Nils Eide, Raffaele Parrozzani, Aleksandra Petrovic, Heinrich Heimann, Anush Amiryan, Tero Kivelä, Juan P. Velazquez-Martin, Anna Bogdali, Shahar Frenkel, Bożena Romanowska-Dixon, Laurence Desjardins, Ian G. Rennie, Rana'a T. Al-Jamal, Hayyam Kiratli, Maria Fili, Jean-Daniel Grange, Martine J. Jager, Iwona Rospond-Kubiak, María Antonia Saornil, S.V. Saakyan, Norbert Bornfeld, Lazaros Konstantinidis, Maria Antonietta Blasi, Sarah E. Coupland, Sachin M. Salvi, Nathalie Cassoux, Marina Marinkovic
Publikováno v:
Ophthalmology. 123:898-907
Purpose To collect comprehensive data on choroidal and ciliary body melanoma (CCBM) in children and to validate hypotheses regarding pediatric CCBM: children younger than 18 years, males, and those without ciliary body involvement (CBI) have more fav
Publikováno v:
Acta Ophthalmologica. 94:99-102
Purpose To report a bilateral uveal melanoma detected in a micrometastasis study. Method Case report. Results At enucleation of a circumpapillary amelanotic mixed melanoma in a patient with ocular melanocytosis, a pigmented lesion in the other eye wa
Autor:
Nils Eide, Dag Tallak Kjærsdalen Berntzen, Ulrik Carling, Bjørn Edwin, Bård I. Røsok, Sven-Petter Haugvik, Eric Dorenberg, Svein Dueland
Publikováno v:
CardioVascular and Interventional Radiology. 38:1532-1541
The purpose of this study was to evaluate treatment response and complications of transarterial chemoembolization using drug-eluting beads loaded with irinotecan (DEBIRI) in patients with liver metastases from uveal melanoma (UM). Patients treated wi
Autor:
Nils, Eide, Ragnar S, Faye, Hanne K, Høifødt, Berit, Sandstad, Geir, Qvale, Rowan, Faber, Peter, Jebsen, Gunnar, Kvalheim, Øystein, Fodstad
Publikováno v:
Acta Ophthalmologica. 93:59-66
Our objective was to study survival rates with the bone marrow (BM) results in a cohort of uveal melanoma patients with long follow-up.Mononuclear cell fractions isolated from BM were examined for tumour cells using our immunomagnetic separation (IMS
Autor:
Tero Kivelä, P. Raffaele, S. Jouhi, Jens Folke Kiilgaard, L. Scheen, Edoardo Midena, Laurence Desjardins, Martine J. Jager, Iwona Rospond-Kubiak, Jd Grange, Nils Eide, Jean-Pierre Caujolle
Publikováno v:
Acta Ophthalmologica. 95
Autor:
Leiv Sandvik, Peter Jebsen, Nils Eide, Øystein Fodstad, Rowan Thomas Faber, Geir A. Qvale, Hanne K. Høifødt, Gunnar Kvalheim, Ragnar S. Faye
Publikováno v:
Pathology oncology research : POR. 25(1)
Approximately 50% of uveal melanoma patients develop metastases. We want to evaluate the effect of stricter criteria on our data from our previous study correlating survival and bone marrow (BM) micrometastasis results using our immunomagnetic separa
Autor:
Ingeborg M. Bachmann, Jürgen Geisler, Hans E. Fjøsne, Trude Eid Robsahm, Marta Nyakas, Lars A. Akslen, Kari D. Jacobsen, Lovise Maehle, Nils Eide, Per Helsing, Oddbjørn Straume, Henrik L. Svendsen, Steinar Aamdal
Publikováno v:
Tidsskrift for Den norske legeforening. 133:2154-2158
Background The incidence of malignant melanoma in Norway is among the highest in the world and rising, with approximately 1 500 persons receiving the diagnosis annually. Correct surgical primary treatment cures 80-90%, while 10-20% experience relapse
Autor:
Peter Jebsen, Rowan Thomas Faber, B. Sandstad, Nils Eide, Geir A. Qvale, Ragnar S. Faye, Gunnar Kvalheim, Hanne K. Høifødt, Øystein Fodstad
Publikováno v:
Acta Ophthalmologica. 87:830-836
Our objective was to introduce immunomagnetic separation (IMS) in ocular research by evaluating the possibility of detecting tumour cells in bone marrow (BM) and peripheral blood (PB) samples and validating the captured cells as melanocytic cells.Mon
Autor:
Lisa Walaas, Nils Eide
Publikováno v:
Acta Ophthalmologica. 87:588-601
Ocular oncologists require a strong indication for intraocular biopsy before the procedure can be performed because it carries a risk for serious eye complications and the dissemination of malignant cells. The purpose of this review is to evaluate th